TW200744598A - Process for the production of freeze-dried preparations containing quinolones - Google Patents

Process for the production of freeze-dried preparations containing quinolones

Info

Publication number
TW200744598A
TW200744598A TW095136062A TW95136062A TW200744598A TW 200744598 A TW200744598 A TW 200744598A TW 095136062 A TW095136062 A TW 095136062A TW 95136062 A TW95136062 A TW 95136062A TW 200744598 A TW200744598 A TW 200744598A
Authority
TW
Taiwan
Prior art keywords
freeze
production
mixture
preparations containing
dried preparations
Prior art date
Application number
TW095136062A
Other languages
English (en)
Inventor
Norihiro Nishimoto
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of TW200744598A publication Critical patent/TW200744598A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
TW095136062A 2005-09-28 2006-09-28 Process for the production of freeze-dried preparations containing quinolones TW200744598A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005282393 2005-09-28

Publications (1)

Publication Number Publication Date
TW200744598A true TW200744598A (en) 2007-12-16

Family

ID=37899754

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095136062A TW200744598A (en) 2005-09-28 2006-09-28 Process for the production of freeze-dried preparations containing quinolones

Country Status (5)

Country Link
US (1) US8129533B2 (zh)
EP (1) EP1930006A4 (zh)
JP (1) JPWO2007037330A1 (zh)
TW (1) TW200744598A (zh)
WO (1) WO2007037330A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961328A (zh) * 2012-12-13 2013-03-13 鼎正动物药业（天津）有限公司 一种左氧氟沙星注射液及其制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928232B2 (en) * 2005-05-20 2011-04-19 Daiichi Sankyo Company, Limited Method for producing asymmetric tetrasubstituted carbon atom-containing compound
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
TWI386401B (zh) * 2006-03-27 2013-02-21 Daiichi Seiyaku Co 醫藥用水合物
JP2009079003A (ja) * 2007-09-26 2009-04-16 Daiichi Sankyo Co Ltd 医薬用水和物を含有する医薬
JP5195655B2 (ja) * 2009-06-11 2013-05-08 富士通株式会社 移動端末、通信システムおよび通信方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
CN103230372B (zh) * 2013-01-17 2016-04-06 北京赛盟医药科技发展有限公司 注射用盐酸莫西沙星粉针及其制备方法
JP2016511273A (ja) * 2013-03-08 2016-04-14 メリンタ セラピューティクス、インク Ｄ−グルシトール，１−デオキシ−１−（メチルアミノ）−，１−（６−アミノ−３，５−ジフルオロピリジン−２−イル）−８−クロロ−６−フルオロ−１，４−ジヒドロ−７−（３−ヒドロキシアゼチジン−１−イル）−４−オキソ−３−キノリンカルボン酸塩の結晶型
JP6487051B2 (ja) * 2014-12-30 2019-03-20 サムヤン バイオファーマシューティカルズ コーポレイションＳａｍｙａｎｇ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ ポリマーナノ粒子の凍結乾燥物、及びその製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57127406A (en) * 1981-01-29 1982-08-07 Nippon Chemiphar Co Ltd Production of crystalline freeze dried powder
JPH06786B2 (ja) * 1984-02-22 1994-01-05 塩野義製薬株式会社 セフアロチンナトリウムの結晶性凍結乾燥製剤の製造法
US4839355A (en) * 1987-09-09 1989-06-13 Sterling Drug Inc. Tricyclic-pyridinylquinoline compounds, their preparation and use
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
JPH02104527A (ja) * 1988-10-11 1990-04-17 Kayaku:Kk １−〔（４´‐ヒドロキシ‐２´‐ブテノキシ）メチル〕‐２‐ニトロイミダゾールの凍結乾燥製剤の製造法
US7176313B2 (en) * 2000-02-09 2007-02-13 Daiichi Pharmaceutical Co., Ltd. Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
IT1319664B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.
DE60130359T2 (de) * 2000-11-20 2008-06-26 Daiichi Sankyo Co., Ltd. Deshalogenverbindungen
JP4384402B2 (ja) 2001-11-30 2009-12-16 富山化学工業株式会社 デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法
DE10204792A1 (de) * 2002-02-06 2003-08-14 Merck Patent Gmbh Lyophilisierte Zubereitung enthaltend Immuncytokine
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961328A (zh) * 2012-12-13 2013-03-13 鼎正动物药业（天津）有限公司 一种左氧氟沙星注射液及其制备方法
CN102961328B (zh) * 2012-12-13 2014-12-03 鼎正动物药业（天津）有限公司 一种左氧氟沙星注射液及其制备方法

Also Published As

Publication number Publication date
EP1930006A1 (en) 2008-06-11
EP1930006A4 (en) 2010-10-13
US20080300403A1 (en) 2008-12-04
WO2007037330A1 (ja) 2007-04-05
US8129533B2 (en) 2012-03-06
JPWO2007037330A1 (ja) 2009-04-09

Similar Documents

Publication Publication Date Title
TW200744598A (en) Process for the production of freeze-dried preparations containing quinolones
NZ603332A (en) Sweet flavor modifier
WO2013049726A3 (en) Processes for making compounds useful as inhibitors of atr kinase
WO2010139979A3 (en) Processes for preparing crystalline forms of dasatinib
CA2826751C (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
MX370390B (es) Compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1, 5-a]pirimidin-3-carboxamida util como inhibidor de cinasa de ataxia telangiectasia mutada (atm) y rad3 relacionados (atr), su preparacion, diferentes formas solidas y sus derivados radiomarcados.
IN2012DN01453A (zh)
WO2007084875A3 (en) Spiro compounds and methods of use
MX2010009414A (es) Derivados de imidazo-[1,2-b]-piridazina para el tratamiento de enfermedad mediada por cinasa de tirosina c-met.
MY181645A (en) Antibacterial quinoline derivatives
WO2010139981A3 (en) Processes for preparing crystalline forms of dasatinib
TW200609221A (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
MX339302B (es) 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
MX2009003313A (es) Acidos quinolona carboxilicos, derivados de los mismos, procesos para su preparacion y su uso como agentes antibacterianos.
MX2012001529A (es) Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-piridazin-6-ilo como moduladores de cinasa de tirosina c-met.
MX2009007413A (es) Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos.
WO2006134491A3 (en) New crystalline form of moxifloxacin hydrochloride and process for its preparation
WO2012030106A3 (en) Production method of intermediate compound for synthesizing medicament
WO2007072092A8 (en) New phenanthridine derivatives as bradykinin antagonists
TW200740729A (en) Methods for preparing glutamic acid derivatives
WO2008020421A3 (en) Compositions comprising calcium citrate malate and methods for making the same
NZ623780A (en) Stable sns-595 compositions and methods of preparation
HK1137431A1 (en) Antibacterial quinoline derivatives
NZ591837A (en) Amino acid derivative
WO2010079506A3 (en) Pharmaceutical composition of aripiprazole